scholarly article | Q13442814 |
P50 | author | Michael Nonnemacher | Q55273616 |
Satinder Dahiya | Q59296143 | ||
P2093 | author name string | Brian Wigdahl | |
P2860 | cites work | Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells | Q36399936 |
Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication | Q36401561 | ||
Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways | Q36499676 | ||
CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. | Q36556421 | ||
Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. | Q36699534 | ||
HIV-1 matrix protein: a mysterious regulator of the viral life cycle | Q36702218 | ||
Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. | Q36710904 | ||
Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies | Q36813044 | ||
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates | Q36882975 | ||
Regulation of HIV-1 latency by T-cell activation. | Q36887625 | ||
HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. | Q37062107 | ||
Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection | Q37066263 | ||
Suppression of HIV-1 replication by microRNA effectors | Q37133970 | ||
APOBEC proteins and intrinsic resistance to HIV-1 infection | Q37140468 | ||
Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes | Q37145340 | ||
Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death | Q37183208 | ||
Cellular reservoirs of HIV-1 and their role in viral persistence | Q37196089 | ||
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs | Q37229398 | ||
Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages | Q37273948 | ||
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells | Q36370102 | ||
CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection | Q36371384 | ||
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression | Q21245193 | ||
Global landscape of HIV-human protein complexes | Q24300336 | ||
Identification of host proteins required for HIV infection through a functional genomic screen | Q24306298 | ||
The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription | Q24307870 | ||
The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling | Q24322710 | ||
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients | Q24538755 | ||
Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr | Q24543218 | ||
Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism | Q24594703 | ||
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid | Q24596282 | ||
CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells | Q24633405 | ||
Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter | Q24634457 | ||
Crystal structure of HIV-1 Tat complexed with human P-TEFb | Q24634569 | ||
Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production | Q24682936 | ||
HIV-1 nef suppression by virally encoded microRNA | Q24803620 | ||
Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? | Q24816505 | ||
Changes in microRNA expression profiles in HIV-1-transfected human cells | Q25257532 | ||
Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication | Q27497968 | ||
DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation | Q28139929 | ||
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans | Q28140638 | ||
Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA | Q28203201 | ||
A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication | Q28245811 | ||
Controlling the elongation phase of transcription with P-TEFb | Q28255518 | ||
Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1 | Q28261598 | ||
Repression of MHC class I gene promoter activity by two-exon Tat of HIV | Q28269206 | ||
Role of viral regulatory and accessory proteins in HIV-1 replication | Q28280802 | ||
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans | Q28345408 | ||
The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product | Q28368083 | ||
Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs | Q42118138 | ||
Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity | Q42157622 | ||
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication | Q42282677 | ||
Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid | Q42485695 | ||
Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. | Q42755157 | ||
Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines | Q42944655 | ||
HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity | Q43716009 | ||
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. | Q43792135 | ||
Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons. | Q44010197 | ||
Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction | Q44483444 | ||
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate | Q44535607 | ||
HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection | Q45345418 | ||
Early viral brain invasion in iatrogenic human immunodeficiency virus infection | Q45868985 | ||
Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement | Q46142126 | ||
Transient-mediated fate determination in a transcriptional circuit of HIV. | Q50642600 | ||
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing | Q50768291 | ||
Targets for human encoded microRNAs in HIV genes | Q57076044 | ||
The HIV-1 Nef protein has a dual role in T cell receptor signaling in infected CD4+ T lymphocytes | Q57565041 | ||
Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1 | Q58377824 | ||
Effects of integration and replication on transcription of the HIV-1 long terminal repeat | Q72571845 | ||
Macrophages as a source of HIV during opportunistic infections | Q73427586 | ||
CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells | Q74587983 | ||
HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1 | Q80089462 | ||
Mechanisms for HIV Tat upregulation of IL-10 and other cytokine expression: kinase signaling and PKR-mediated immune response | Q81770906 | ||
HIV-Nef and AIDS pathogenesis: are we barking up the wrong tree? | Q84602577 | ||
HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination | Q28474374 | ||
Epigenetic regulation of HIV-1 latency by cytosine methylation | Q28475636 | ||
Ribo-gnome: the big world of small RNAs | Q29615681 | ||
Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication | Q29616375 | ||
HIV-1 integration in the human genome favors active genes and local hotspots | Q29618457 | ||
HIV-1 accessory proteins--ensuring viral survival in a hostile environment | Q29619538 | ||
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 | ||
HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction | Q30159721 | ||
Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses | Q30391530 | ||
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence | Q30488246 | ||
Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery | Q31577177 | ||
OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions | Q31814830 | ||
Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology | Q32068509 | ||
Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity | Q33220546 | ||
HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT | Q33265220 | ||
NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site | Q33266806 | ||
The Ebola virus VP35 protein is a suppressor of RNA silencing | Q33288729 | ||
HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR | Q33292464 | ||
Interfering RNA and HIV: reciprocal interferences | Q33372109 | ||
miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1 | Q33400321 | ||
The SET complex acts as a barrier to autointegration of HIV-1 | Q33415459 | ||
Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation | Q33425135 | ||
Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection | Q33476165 | ||
CpG methylation controls reactivation of HIV from latency | Q33495565 | ||
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation | Q33508788 | ||
Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage | Q33587139 | ||
Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression | Q33593821 | ||
Association of Tat with Promoters of PTEN and PP2A Subunits Is Key to Transcriptional Activation of Apoptotic Pathways in HIV-Infected CD4+ T Cells | Q33700607 | ||
The macrophage in HIV-1 infection: from activation to deactivation? | Q33810779 | ||
Vpr-host interactions during HIV-1 viral life cycle | Q33828332 | ||
A re-examination of global suppression of RNA interference by HIV-1. | Q33840754 | ||
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells | Q33851786 | ||
Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage | Q33864438 | ||
Combinatorial latency reactivation for HIV-1 subtypes and variants | Q33877492 | ||
Protein phosphatase-1 activates CDK9 by dephosphorylating Ser175. | Q33886004 | ||
Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon | Q33889326 | ||
Cellular microRNA and P bodies modulate host-HIV-1 interactions | Q37391014 | ||
Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid | Q37406083 | ||
Chromatin dynamics associated with HIV-1 Tat-activated transcription | Q37589012 | ||
Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis | Q37596477 | ||
The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors | Q37613764 | ||
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies | Q37644561 | ||
Curing HIV: Pharmacologic approaches to target HIV-1 latency | Q37645582 | ||
Macrophage signaling in HIV-1 infection | Q37728093 | ||
HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS. | Q37785252 | ||
Analysis of the roles of HIV-derived microRNAs | Q37816443 | ||
Epigenetic regulation of HIV latency | Q37829626 | ||
A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system | Q37829628 | ||
Macrophages and HIV-1. | Q37898469 | ||
The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models | Q37900419 | ||
Mechanisms of RNA interference in the HIV-1-host cell interplay. | Q37907829 | ||
Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system | Q37974980 | ||
High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. | Q38341208 | ||
Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2. | Q38356666 | ||
HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. | Q38356699 | ||
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. | Q39270892 | ||
Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR | Q39595632 | ||
Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction | Q39712159 | ||
The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. | Q39883609 | ||
Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression | Q39885717 | ||
SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro | Q39902859 | ||
Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency | Q39933477 | ||
Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. | Q40009476 | ||
TAT-Hsp40 inhibits oxidative stress-mediated cytotoxicity via the inhibition of Hsp70 ubiquitination. | Q40015511 | ||
Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study | Q40130110 | ||
Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation | Q40132386 | ||
Suppression of microRNA-silencing pathway by HIV-1 during virus replication | Q40166750 | ||
Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes | Q40280905 | ||
Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling | Q40339753 | ||
A role for LEDGF/p75 in targeting HIV DNA integration | Q40346940 | ||
Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages | Q40358843 | ||
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells | Q40435387 | ||
Regulation of human immunodeficiency virus 1 transcription by nef microRNA. | Q40456215 | ||
HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB. | Q40478718 | ||
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression | Q40507650 | ||
A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. | Q40557365 | ||
Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts | Q40572781 | ||
HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. | Q40690555 | ||
Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. | Q41868116 | ||
Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence | Q41929326 | ||
Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes | Q41994305 | ||
Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency | Q42100247 | ||
Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes | Q33895074 | ||
Emergence of a complex relationship between HIV-1 and the microRNA pathway | Q34025960 | ||
Role of chromatin in HIV-1 transcriptional regulation | Q34033128 | ||
Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns | Q34206910 | ||
Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR. | Q34387337 | ||
Step out of the groove: epigenetic gene control systems and engineered transcription factors | Q34531990 | ||
Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription | Q34537015 | ||
The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit | Q34544409 | ||
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy | Q34588169 | ||
Hematopoietic stem/precursor cells as HIV reservoirs. | Q34610023 | ||
Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation | Q34647406 | ||
Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment | Q34671618 | ||
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes | Q34695803 | ||
Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients | Q34725556 | ||
Histone deacetylase inhibitors and HIV latency | Q34816844 | ||
HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention | Q34957142 | ||
Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders | Q35022812 | ||
HIV Tat, its TARgets and the control of viral gene expression | Q35088029 | ||
Inhibition of PP2A by LIS1 increases HIV-1 gene expression | Q35098682 | ||
Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. | Q35114694 | ||
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells | Q35213780 | ||
MicroRNAs and human retroviruses | Q35226238 | ||
Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. | Q35266342 | ||
Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity | Q35761152 | ||
Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients | Q35799435 | ||
Interplay between HIV-1 infection and host microRNAs | Q35823730 | ||
Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes. | Q35826285 | ||
Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. | Q35826464 | ||
Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. | Q35832979 | ||
The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor | Q35834594 | ||
Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. | Q35866513 | ||
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection | Q36225040 | ||
siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code | Q36325641 | ||
P433 | issue | Pt 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1151-1172 | |
P577 | publication date | 2012-03-14 | |
P1433 | published in | Journal of General Virology | Q6295245 |
P1476 | title | Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development | |
P478 | volume | 93 |